OMCL Stock Analysis: Buy, Sell, or Hold?
OMCL - Omnicell Inc
$32.62
-0.13 (-0.40%)
▼
5d:
-4.93%
30d:
-20.63%
90d:
-29.7%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When OMCL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OMCL trading at deep discount. Market pricing in -10.2% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: OMCL trading at deep discount. Market pricing in -10.2% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$77.60
Based on 11.6% avg growth
INTRINSIC VALUE TODAY
$48.19
32.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OMCL is currently trading at $32.62, which is considered oversold relative to its 30-day fair value range of $34.17 to $40.84. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.7) compared to its historical average (21.6). Remarkably, the market is currently pricing in an annual earnings decline of 10.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OMCL is showing sideways momentum. The price is currently testing key support at $32.19. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $57.43 (+75.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OMCL is showing sideways momentum. The price is currently testing key support at $32.19. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $57.43 (+75.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$34.17 -
$40.84
Company Quality Score
54/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 75.4% below Wall St target ($57.43)
Fair Price Analysis
30-Day Fair Range
$34.17 -
$40.84
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$2.45
(7.5%)
Support & Resistance Levels
Support Level
$32.19
Resistance Level
$35.62
Current Trend
Sideways
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.69
Wall Street Target
$57.43
(+75.4%)
Revenue Growth (YoY)
2.3%
Earnings Growth (YoY)
-35.9%
Profit Margin
0.2%
Valuation Discount vs History
-10.2% cheaper
PE vs Historical
15.7 vs 21.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-10.2%
(market-implied from PE analysis)
1-Year Target
$29.48
(-10%)
2-Year Target
$26.53
(-19%)
3-Year Target
$23.87
(-27%)
3-Yr Target (if PE normalizes)
(PE: 16→22)
$32.87
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 19.2%)
$79.19
(+142%)
Base:
(SPY PE: 15.7, Growth: 19.2%)
$55.46
(+69%)
Bear:
(PE: 13.3, Growth: 19.2%)
$47.14
(+44%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Forward PE: 29.50 | Forward EPS (Implied): $1.16
Bull Case
$41.43
(+21%)
Analyst growth 15.0%, PE expands to 31.0
Base Case
$34.31
(0%)
Market implied 0.0%, PE stable at 29.5
Bear Case
$26.25
(-24%)
Severe decline -15.0%, PE contracts to 26.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.7 to 21.6
Stabilization Target:
$45.09
(+37.7%)
PE Expansion Potential:
+37.7%
Share & Embed Analysis
Last updated: March 30, 2026 10:20 AM ET
Data refreshes hourly during market hours. Next update: 11:20 AM
Data refreshes hourly during market hours. Next update: 11:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMCL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Corey J Manley
SELL
7405 shares
2026-03-16
Corey J Manley
SELL
6106 shares
2026-01-08
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 50 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 46 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 58 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 58 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 60 BUY |
